Theraclion SA (EPA:ALTHE)
France
· Delayed Price · Currency is EUR 0.572
+0.002 (0.35%)
Mar 9, 2026, 3:33 PM CET
Theraclion Revenue
Theraclion had revenue of 944.00K EUR in the half year ending June 30, 2025, a decrease of -3.77%. This brings the company's revenue in the last twelve months to 1.87M, up 210.90% year-over-year. In the year 2024, Theraclion had annual revenue of 830.21K, down -54.44%.
Revenue (ttm)
1.87M
Revenue Growth
+210.90%
P/S Ratio
14.29
Revenue / Employee
58.57K
Employees
31
Market Cap
26.78M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 830.21K | -992.01K | -54.44% |
| Dec 31, 2023 | 1.82M | 586.77K | 47.49% |
| Dec 31, 2022 | 1.24M | -245.50K | -16.58% |
| Dec 31, 2021 | 1.48M | 736.95K | 99.05% |
| Dec 31, 2020 | 744.00K | -2.39M | -76.23% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novacyt | 22.69M |
| Implanet | 11.10M |
| Ikonisys | 1.47M |
| Diagnostic Medical Systems | 49.47M |
| Mauna Kea Technologies | 8.18M |
| Biosynex | 97.95M |
| SpineGuard | 4.32M |
| Bluelinea Société Anonyme | 11.68M |